Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 2
1994 5
1995 2
1997 2
1999 1
2000 2
2001 5
2002 6
2003 6
2004 6
2005 4
2006 7
2007 8
2008 8
2009 3
2010 4
2011 4
2012 4
2013 2
2014 3
2015 4
2017 2
2018 1
2020 7
2021 14
2022 9
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

118 results

Results by year

Filters applied: . Clear all
Page 1
IgA dominates the early neutralizing antibody response to SARS-CoV-2.
Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Claër L, Quentric P, Fadlallah J, Devilliers H, Ghillani P, Gunn C, Hockett R, Mudumba S, Guihot A, Luyt CE, Mayaux J, Beurton A, Fourati S, Bruel T, Schwartz O, Lacorte JM, Yssel H, Parizot C, Dorgham K, Charneau P, Amoura Z, Gorochov G. Sterlin D, et al. Among authors: charneau p. Sci Transl Med. 2021 Jan 20;13(577):eabd2223. doi: 10.1126/scitranslmed.abd2223. Epub 2020 Dec 7. Sci Transl Med. 2021. PMID: 33288662 Free PMC article.
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F; French COVID Cohort Study Group; CORSER Study Group; Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H. Planchais C, et al. Among authors: charneau p. J Exp Med. 2022 Jul 4;219(7):e20220638. doi: 10.1084/jem.20220638. Epub 2022 Jun 15. J Exp Med. 2022. PMID: 35704748 Free PMC article.
Blood-brain barrier-specific properties of a human adult brain endothelial cell line.
Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO. Weksler BB, et al. Among authors: charneau p. FASEB J. 2005 Nov;19(13):1872-4. doi: 10.1096/fj.04-3458fje. Epub 2005 Sep 1. FASEB J. 2005. PMID: 16141364
Use of lentiviral vectors in vaccination.
Ku MW, Charneau P, Majlessi L. Ku MW, et al. Among authors: charneau p. Expert Rev Vaccines. 2021 Dec;20(12):1571-1586. doi: 10.1080/14760584.2021.1988854. Epub 2021 Oct 11. Expert Rev Vaccines. 2021. PMID: 34620025 Review.
Lentiviral Vectors as a Vaccine Platform against Infectious Diseases.
Nemirov K, Bourgine M, Anna F, Wei Y, Charneau P, Majlessi L. Nemirov K, et al. Among authors: charneau p. Pharmaceutics. 2023 Mar 5;15(3):846. doi: 10.3390/pharmaceutics15030846. Pharmaceutics. 2023. PMID: 36986707 Free PMC article. Review.
HIV-derived vectors for therapy and vaccination against HIV.
Di Nunzio F, Félix T, Arhel NJ, Nisole S, Charneau P, Beignon AS. Di Nunzio F, et al. Among authors: charneau p. Vaccine. 2012 Mar 28;30(15):2499-509. doi: 10.1016/j.vaccine.2012.01.089. Epub 2012 Feb 13. Vaccine. 2012. PMID: 22342915 Review.
BNT162b2 vaccine-induced humoral and cellular responses against SARS-CoV-2 variants in systemic lupus erythematosus.
Moyon Q, Sterlin D, Miyara M, Anna F, Mathian A, Lhote R, Ghillani-Dalbin P, Breillat P, Mudumba S, de Alba S, Cohen-Aubart F, Haroche J, Pha M, Boutin THD, Chaieb H, Flores PM, Charneau P, Gorochov G, Amoura Z. Moyon Q, et al. Among authors: charneau p. Ann Rheum Dis. 2022 Apr;81(4):575-583. doi: 10.1136/annrheumdis-2021-221097. Epub 2021 Oct 4. Ann Rheum Dis. 2022. PMID: 34607791 Free PMC article.
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T. Dufloo J, et al. Among authors: charneau p. Cell Rep Med. 2021 May 18;2(5):100275. doi: 10.1016/j.xcrm.2021.100275. Epub 2021 Apr 20. Cell Rep Med. 2021. PMID: 33899033 Free PMC article.
118 results